Literature DB >> 3828791

Cerebrospinal fluid levels of uric acid in dogs and the effect of allopurinol.

P Kim, T L Yaksh, P C Burnett, M R Blum, T M Sundt.   

Abstract

Uric acid (UA) levels in cerebrospinal fluid (CSF) were measured in 15 dogs and the entrance and effect of allopurinol, a specific inhibitor of enzyme xanthine oxidase (XO), in brain were measured by sampling CSF in dogs. Allopurinol was administered intravenously 25 mg/kg every 6 h for 48 h. Drug level as well as UA level in plasma and CSF was measured by high-performance liquid chromatography. A significant concentration of allopurinol was achieved in CSF and a remarkable suppression of CSF UA level was observed at all time points measured. Decrease of UA in CSF level was more pronounced than in plasma, and was not considered secondary to suppression of systemic XO activity. Therefore the regimen employed was proven to be sufficient to suppress XO activity in the subarachnoid space, and drug concentration observed in CSF during this period (5 micrograms/ml) is considered to be in the therapeutic range.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3828791     DOI: 10.1016/0006-8993(87)91050-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  Early postnatal allopurinol does not improve short term outcome after severe birth asphyxia.

Authors:  M J N L Benders; A F Bos; C M A Rademaker; M Rijken; H L Torrance; F Groenendaal; F van Bel
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-01-20       Impact factor: 5.747

2.  Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors.

Authors:  A P Schmidt; A E Böhmer; C Antunes; C Schallenberger; L O Porciúncula; E Elisabetsky; D R Lara; D O Souza
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.